Protocol for Radiofrequency Ablation of Pulmonary Neoplasms
Sponsor
Oncology Specialties, Alabama (Other)
Overall Status
Terminated
CT.gov ID
NCT00232128
Collaborator
(none)
1
Study Details
Study Description
Brief Summary
This research trial involves the development of a new treatment for lung tumors. It is for patients whose tumor cannot be surgically removed, have refused surgery, or the tumor has not responded well to other forms of treatment. This treatment uses a needle probe to deliver energy into the lung tumor. This probe is placed utilizing a CT scan image. The energy heats the tumor causing tumor cell death.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Protocol for Radiofrequency Ablation of Pulmonary Neoplasms
Study Start Date
:
Jun 1, 2003
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
19 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria: The patients enrolled in this study should be judged to have sufficient survival to benefit from control of local disease and include at least one of the following:
-
unresectable primary or metastatic lung tumors
-
may benefit from multiple modalities of therapy
-
chemotherapeutic or radiation oncologic options have been exhausted
Exclusion Criteria:
- co-existing morbidities that preclude the use of surgery
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Comprehensive Cancer Institute | Huntsville | Alabama | United States | 35801 |
Sponsors and Collaborators
- Oncology Specialties, Alabama
Investigators
- Principal Investigator: Marshall T. Schreeder, M.D., Comprehensive Cancer Institute
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00232128
Other Study ID Numbers:
- CCI LUN 02
First Posted:
Oct 4, 2005
Last Update Posted:
Jan 12, 2007
Last Verified:
May 1, 2006